BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15177682)

  • 1. Comparative genomics: the evolutionary history of the Bcl-2 family.
    Lanave C; Santamaria M; Saccone C
    Gene; 2004 May; 333():71-9. PubMed ID: 15177682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of core structural residues in the sequentially diverse and structurally homologous Bcl-2 family of proteins.
    Lama D; Sankararamakrishnan R
    Biochemistry; 2010 Mar; 49(11):2574-84. PubMed ID: 20141168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins.
    Gurudutta GU; Verma YK; Singh VK; Gupta P; Raj HG; Sharma RK; Chandra R
    FEBS Lett; 2005 Jul; 579(17):3503-7. PubMed ID: 15949801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells.
    Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA
    Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region.
    Coultas L; Pellegrini M; Visvader JE; Lindeman GJ; Chen L; Adams JM; Huang DC; Strasser A
    Cell Death Differ; 2003 Feb; 10(2):185-92. PubMed ID: 12700646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators.
    Aouacheria A; Brunet F; Gouy M
    Mol Biol Evol; 2005 Dec; 22(12):2395-416. PubMed ID: 16093567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain.
    Hossini AM; Geilen CC; Fecker LF; Daniel PT; Eberle J
    Oncogene; 2006 Apr; 25(15):2160-9. PubMed ID: 16288206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in the development and maintenance of the immune system.
    Opferman JT; Korsmeyer SJ
    Nat Immunol; 2003 May; 4(5):410-5. PubMed ID: 12719730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
    Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
    Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
    Yin XM; Oltvai ZN; Korsmeyer SJ
    Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family.
    Scorilas A; Kyriakopoulou L; Yousef GM; Ashworth LK; Kwamie A; Diamandis EP
    Genomics; 2001 Mar; 72(2):217-21. PubMed ID: 11401436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
    Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
    J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bax activation and mitochondrial insertion during apoptosis.
    Lalier L; Cartron PF; Juin P; Nedelkina S; Manon S; Bechinger B; Vallette FM
    Apoptosis; 2007 May; 12(5):887-96. PubMed ID: 17453158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
    Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
    Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins.
    Joseph MK; Solomon LR; Petros AM; Cai J; Simmer RL; Zhang H; Rosenberg S; Ng SC
    Oncogene; 2004 Jan; 23(3):835-8. PubMed ID: 14737118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
    Zhou H; Hou Q; Chai Y; Hsu YT
    Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL-2 gene family and the regulation of programmed cell death.
    Korsmeyer SJ
    Cancer Res; 1999 Apr; 59(7 Suppl):1693s-1700s. PubMed ID: 10197582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evolution of apoptotic pathways: cloning of key domains from sponges (Bcl-2 homology domains and death domains) and their phylogenetic relationships.
    Wiens M; Krasko A; Müller CI; Müller WE
    J Mol Evol; 2000 Jun; 50(6):520-31. PubMed ID: 10835482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for crucial electrostatic interactions between Bcl-2 homology domains BH3 and BH4 in the anti-apoptotic Nr-13 protein.
    Lalle P; Aouacheria A; Dumont-Miscopein A; Jambon M; Venet S; Bobichon H; Colas P; Deléage G; Geourjon C; Gillet G
    Biochem J; 2002 Nov; 368(Pt 1):213-21. PubMed ID: 12133006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How the Bcl-2 family of proteins interact to regulate apoptosis.
    van Delft MF; Huang DC
    Cell Res; 2006 Feb; 16(2):203-13. PubMed ID: 16474435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.